Bibliographic Details
| Title: |
D.4 Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy (EMBARK): Pivotal Phase 3 primary results. |
| Authors: |
Mendell, JR, Muntoni, F, McDonald, CM, Mercuri, EM, Ciafaloni, E, Komaki, H, Leon-Astudillo, C, Nascimento, A, Proud, C, Schara-Schmidt, U, Veerapandiyan, A, Zaidman, CM, Guridi, M, Murphy, AP, Reid, C, Wandel, C, Darton, E, Mason, S, Potter, RA, Singh, T, et al |
| Source: |
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2024 Supplement; Vol. 51. |
| Journal Info: |
Publisher: Cambridge University Press ISSN: 0317-1671 |
| Database: |
MEDLINE Ultimate |
